Share Your Thoughts on our Terminology Server! Let us know your insights and help enhance our services. The survey is open from Nov 19 to Dec 3, 2024. Your feedback matters! Learn More >

Share this page:

file Canadian Clinical Drug Data Set Conference call -June 20th 11am ET

  • Posts: 250
7 years 4 months ago #2771 by Beverly Knight
thankyou for those who participated in the discussion. The slides used on the call can be found here 20170620-Discussion Slides

The meeting notes can be found here; 20170620 - Canadian Clinical Drug Data Set Meeting Notes

If anyone finds I have misrepresented the discussion, please let me know.

Beverly

Please Log in or Create an account to join the conversation.

  • Posts: 44
7 years 5 months ago #2731 by Monica Hazra
It would be really helpful to clarify the purpose of paper 14. Is this in response to the opioid crisis and are you setting up the framework for the misuse of other agents ? Paper 14 makes reference to prescription opioids and those available as OTC products. But, the opioid crisis includes opioids that patients are using recreationally. IT would be nice when all data is captured digitally, should there be another crisis.... to run a DUR and start inviting patients to have naloxone on hand/ target education to these individuals.

Please Log in or Create an account to join the conversation.

  • Posts: 250
7 years 5 months ago #2706 by Beverly Knight
hi
thankyou for your comments. I think it is best to discuss on the.

here is my initial thoughts; Since our focus is the national drug Terminology itself, we have focused on identifying the medicinal products only. And now we understand there is a need to not only identify the medicinal products for clinical and digital health use, but also identify some other characteristics such as whether the medicinal product happens to be an opioid or perhaps a narcotic.
look forward to the discussion
beverly

Please Log in or Create an account to join the conversation.

  • Posts: 44
7 years 5 months ago #2699 by Monica Hazra
Thank you for all the work that went into Paper 14. Are you referring to opioid management in cancer and non cancer conditions ? Or is the focus on non cancer pain management ? Thanks.

Please Log in or Create an account to join the conversation.

  • Posts: 250
7 years 5 months ago #2693 by Beverly Knight
hi
we have the following topics with discussion papers for you to review prior to the call to enable a good discussion.
Manufactured Product DIN Granularity issue:
Issue Paper 12, Manufactured Product and DIN Granularity

and
Supporting Opiod Management using the Canadian Clinical Drug Data Set
Issue Paper 14, Supporting Opiod Management Using the CCDD

Look forward to the discussion
Beverly

Please Log in or Create an account to join the conversation.

  • Posts: 44
7 years 5 months ago #2689 by Monica Hazra
Prior to the meeting, is there anything to review ?

Please Log in or Create an account to join the conversation.

Moderators: Linda MonicoSeema Nayani

InfoCentral logo

Improving the quality of patient care through the effective sharing of clinical information among health care organizations, clinicians and their patients.